Action of Photodynamic Therapy on Wound Quality and Tissue Repair in the Diabetic Foot
NCT06416462
Summary
Diabetic foot ulcer affects 10.5% of the Brazilian/world population, compromising the quality of life of these patients and burdening the public health system. Studies show that antimicrobial photodynamic therapy (aPDT) accelerates its repair, however, there is not enough evidence for decision-making in clinical practice, which prevents this treatment from being used on a large scale. Controlled and randomized clinical studies are needed to increase the level of evidence on this subject, promoting the improvement of the quality of life of people affected by diabetic foot ulcers. The aim of this study is to analyze the action of antimicrobial photodynamic therapy on the quality of the wound and tissue repair process using the Bates-Jensen scale in people affected by diabetic foot wounds.
Eligibility
Inclusion Criteria: * both sexes * chronic wounds originating from the neuropathic diabetic foot * contaminated lesions * total score obtained on the Bates-Jensen scale between 13 and 60 * who submits all requested exams Exclusion Criteria: * wounds with etiologies that are not related to the diabetic foot * ischemic diabetic foot who has an ankle-brachial index with a value between 0.7 and 1.3. * glycated hemoglobin greater than 8%.
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06416462